Fidelity reverses many valuation markdowns, as Stemcentrx VC predicted

Stuart Peterson, the Artis Ventures co-founder whose firm made a killing on AbbVie's purchase of Stemcentrx last week, predicted that Fidelity would raise its valuation estimates on venture-backed companies it slashed beginning last fall...